NeuroOne Medical Tech Earnings Preview
Portfolio Pulse from Benzinga Insights
NeuroOne Medical Tech (NASDAQ:NMTC) is scheduled to release its quarterly earnings report on February 13, 2024, with an expected EPS of $-0.14. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in an 11.05% share price drop. Shares are currently trading at $1.45, down 18.5% over the last year, indicating a bearish sentiment among long-term shareholders.
February 12, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeuroOne Medical Tech is expected to report an EPS of $-0.14 for the upcoming quarter. Historical performance shows a mixed reaction to earnings announcements, with the last quarter beating estimates but leading to an 11.05% drop in share price. Currently, shares are trading at $1.45, reflecting an 18.5% decrease over the past year.
Given the historical negative reaction to earnings beats and the overall 18.5% decrease in share price over the past year, it's likely that NMTC's stock price may face downward pressure in the short term, especially if the earnings report fails to exceed expectations significantly or if the future guidance is not optimistic.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100